Anesthesia just wants Titan so that when we spill the foley urine bag all over the robot and short it, it is only $600k to replace, not $2.5mil.
I can go on and on. We just moved our ISRG's to larger rooms this year, but last year we somehow managed to have the ISRG bot in the smallest OR and everyone was cramped. Titan? Small rooms, meh, no big deal.
I'm an under 30yo anesthetist and own shares in TITXF. I have a mix of investments now in biotech and oil/gas, as I was an engineer before switching to healthcare. TITXF is not my most speculative position. The fact that it has cash on hand, a steady stepwise pattern, vested and discrete management, and a good list of pros/teaching institutions attracts me.
As for PPS, ISRG doubled about every year starting from '03. That ROI requires solid execution. Pumpers on here that want to see it go faster are either oblivious, or they want a buyout which is probably more likely given Titan is "second to the market" and needs help with industrialization. I just want a good product to come to the market. The rest will fall into place. If I can sell next year at $12 (1000%) from my original investment, I could pay for upcoming medical school in full, but I'm not banking on 1000%. I'm banking on 100% annual, if that.
News 
Market Data 
Discover 
AI
